Michael Stefanek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael Stefanek has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Caryn Lerman
1 shared publicationCheryl Enger
1 shared publicationJudith Benkendorf
1 shared publicationLynn Hartmann
CancerNet, National Cancer Institute (1)
1 shared publicationSusan Flamm Honig
1 shared publicationWendy Nelson
CancerNet, National Cancer Institute (1)
1 shared publication
Latest Publications
- Open Access
- 5 September 2001
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 93 (17) , 1297
Risk-Reduction Mastectomy: Clinical Issues and Research Needs
Risk-reduction mastectomy (RRM), also known as bilateral prophylactic mastectomy, is a controversial clinical option for women who are at increased risk of breast cancer. High-risk women, including women with a strong family history of breast cancer and BRCA1/2 mutation carriers, have several clinical options: risk-reduction surgery (bilateral mastectomy and bilateral oophorectomy), surveillance (mammography, clinical breast examination, and breast self-examination), and chemoprevention (tamoxifen). We review research in a number of areas central to our understanding of RRM, including recent data on 1) the effectiveness of RRM in reducing breast cancer risk, 2) the perception of RRM among women at increased risk and health-care providers, 3) the decision-making process for follow-up care of women at high risk, and 4) satisfaction and psychological status after surgery. We suggest areas of future research to better guide high-risk women and their health-care providers in the decision-making process.
- 5 September 2001
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 93 (17) , 1297
Open AccessRisk-Reduction Mastectomy: Clinical Issues and Research Needs
Risk-reduction mastectomy (RRM), also known as bilateral prophylactic mastectomy, is a controversial clinical option for women who are at increased risk of breast cancer. High-risk women, including women with a strong family history of breast cancer and BRCA1/2 mutation carriers, have several clinical options: risk-reduction surgery (bilateral mastectomy and bilateral oophorectomy), surveillance (mammography, clinical breast examination, and breast self-examination), and chemoprevention (tamoxifen). We review research in a number of areas central to our understanding of RRM, including recent data on 1) the effectiveness of RRM in reducing breast cancer risk, 2) the perception of RRM among women at increased risk and health-care providers, 3) the decision-making process for follow-up care of women at high risk, and 4) satisfaction and psychological status after surgery. We suggest areas of future research to better guide high-risk women and their health-care providers in the decision-making process.
- 1 September 1999
- Published by Elsevier in Preventive Medicine
- Vol. 29 (3) , 216-221
Bilateral Prophylactic Mastectomy Decision Making: A Vignette Study
- 1 September 1999
- Published by Elsevier in Preventive Medicine
- Vol. 29 (3) , 216-221
Bilateral Prophylactic Mastectomy Decision Making: A Vignette Study